Geography matters. 10 October, European Parliament, Brussels 15:30 18:00

Transcription

1 Geography matters Inequalities in Access to Stroke Care and Innovation in Europe Depending on where you live in the EU, you could be seven times less likely to survive a stroke. How can we end the stroke care lottery? 10 October, European Parliament, Brussels 15:30 18:00

2 Programme Registration Event starts Opening remarks MEP Aldo Patriciello, (EPP, Italy) Prof. Valeria Caso, ESO President Monique Lindhout, SAFE board member Presentation of the ESO-led survey on current stroke practices in Europe Prof. Dr. Urs Fischer, ESO Secretary General and MD MSc Extraordinarius for Acute Neurology and Stroke Co-Director Clinical Trial Unit Bern, University of Bern Organising the stroke care pathway to introduce innovative treatments Prof. Tony Rudd, NHS England National Clinical Director for Stroke, Professor of Stroke Medicine at Kings College London Patient testimonies: life after stroke Panel session: Ensuring access to innovative treatments: national experiences UK: Prof. Tony Rudd, National Clinical Director for Stroke with NHS England and Professor of Stroke Medicine at King s College London. Italy: Dr. Rodolfo Grella, Medical Director Stroke Unit of the Mediterranean Neurological Institute Neuromed. Estonia: Prof. Dr. Janika Kõrv, Associate Professor in Neurology, University of Tartu. Switzerland: Prof. Dr. Urs Fischer, ESO Secretary General and MD MSc Extraordinarius for Acute Neurology and Stroke Co-Director Clinical Trial Unit Bern, University of Bern. Call to Action Prof. Valeria Caso, ESO President Q&A Conclusion of the discussion and final remarks MEP Aldo Patriciello, (EPP, Italy) Networking coffee Event ends

3 Speakers biographies Prof. Valeria Caso, ESO President Valeria Caso is a stroke neurologist at the University of Perugia Stroke Unit. She earned her PhD from the University of Perugia in stroke medicine in 2003 and has been recently certified in the role of associate professor in Neurology. Valeria Caso has authored and co-authored more than 200 published papers and book-chapters. She is a past member of the JNNP Editorial Board. She has served as peer reviewer to over 30 international journals including JNNP, CVD, Stroke, Neurology and Lancet Neurology for more than a total of 200 papers. She has been involved in 20 multicentre trials serving in various positions including steering committees. She supervised several masters, residents and MD-theses. She is currently actively involved in international research projects on cervical artery dissections, heart and brain, intracerebral haemorrhage, and acute stroke treatment. Her primary interest is in the treatment and prevention of stroke in women. MEP Aldo Patriciello Aldo Patriciello was elected Member of the European Parliament in In his current third term, he is a member of the Group of the European People s Party (EPP), treasurer for the Italian Delegation within the EPP as well as a member of the Committee on Industry, Research and Energy (ITRE) and substitute member of the Committee on the Environment, Public Health and Food Safety (ENVI). MEP Patriciello was born in Venafro, Italy. Next to his political activities, he leads a group of thirty companies, mainly in the health and scientific research sectors. He started working in a small family construction company and helped it to grow into a major economic and productive group of his home region. From 1995 to 2006 and before being elected to the European Parliament, MEP Patriciello served as Member of the Regional Council of Molise, Vice-Chairman of the Regional Council, as Molise Regional Councillor responsible for the budget, transport, agriculture and production activities and Vice-president of the Regional Government.

4 Prof. Urs Fischer Urs Fischer is a Professor for Acute Neurology and Stroke at the department of neurology, University Hospital Bern, and co-director of the Clinical Trial Unit (CTU), University of Bern. He studied in Bern, London, San Francisco and Lomé and graduated in He trained as a neurologist in Bern. In 2008/2009 he completed a MSc in Research in Clinical Neurology at the University of Oxford. In 2014 he became an associate professor and in 2015 he was elected Professor for Acute Neurology and Stroke at the University of Bern (Extraordinarius). He is the cochair of the stroke center Bern and chair of the department of acute neurology. He is co-director of the Clinical Trial Unit at the University of Bern. Urs Fischer is a clinical researcher and his main research interest involves diagnosis, management, treatment and outcome of patients with acute neurological diseases, especially of patients with acute ischemic and hemorrhagic stroke. He is participating in multiple preventive, diagnostic and acute treatment trials and stroke registries. He is co-principal investigator of the SWITCH study, principal investigator of the ELAN trial and co-principal investigator of the SWIFT DIRECT trial. Urs Fischer is active in National and European Stroke Societies: he is Secretary General of the European Stroke Organisation (ESO), board member of the Swiss Neurological Society and he is co-founder the ESO ESMINT ESNR Stroke Winter School, which is regularly held at the University Hospital in Bern, Switzerland. Prof. Anthony Rudd Prof. Anthony Rudd was appointed consultant geriatrician and general physician at St Thomas in He has helped develop St Thomas stroke services, which are rated amongst the best in the country. For the last 10 years, Anthony has focused solely on stroke care running the stroke unit and outpatient service. Anthony has been the Stroke Programme Director at the Royal College of Physicians since 1995 and a trustee of the UK Stroke association from Most importantly, he is the London Stroke Clinical Director since 2010 and the National Clinical Director for Stroke with NHS England since From 2010 he has been a Professor of Stroke Medicine at Kings College London. In 2013, Prof. Rudd received the honour of the Commander of the Order of the British Empire (CBE) for his services to stroke medicine, an award attributed for one s leading role at regional level.

5 Prof. Janika Kõrv Janika Kõrv MD, Ph.D. graduated from the University of Tartu, Estonia. After completing a specialization in neurology and PhD studies, she started her career as a neurologist at Tartu University Hospital. In 2010, she was elected Associate Professor at the Department of Neurology and Neurosurgery, University of Tartu. Dr Kõrv s main research interests are epidemiology of stroke, acute stroke management, and young stroke. Besides being engaged in national clinical research projects and supervising PhD students, she has been involved in numerous international stroke trials as well as other international research collaborations as the National Coordinator. She has published more than 200 papers and served as reviewer for several peer reviewed journals. Janika is the chair of the Estonian Stroke Initiative, board member of the Estonian L. Puusepp Society of Neurologists and Neurosurgeons, national delegate at the European Academy of Neurology, and Fellow of ESO. Since 2015 she is the chairperson of the Nordic Stroke Society. Janika Kõrv has been the project leader of the Estonian Stroke Guideline, National Stroke Audits (2010, 2013) and current stroke quality indicators program. She is a member of ESO guideline working groups Dr. Rodolfo Grella Dr. Rodolfo Grella currently works at the Stroke Unit at IRCCS Neurological Mediterranean Institute. He specialises in geriatrics and diseases associated with ageing. He has been teaching nursing science under general physiopathology at the renowned La Sapienza University in Rome. Rodolfo completed a PhD focusing on metabolism and inventory and a PhD in geriatrics and physiopathology at Napoli University. Dr Grella has authored and co-authored more than 50 international scientific publications. He is actively involved in several projects such as Study and Monitoring of Glycaemia and Study, Assessment and Care of vasculophatic and neuropathic complications in diabetes. Monique Lindhout Monique graduated as a Speech and Language Practitioner in 1981 and started working with people with neurological speech, language and/or swallow disorders, in that same year. In 1986, she became a Board member of the Dutch Aphasia Association and has been involved in patient organisations ever since. She was elected as Secretary General of the Association lnternationale Aphasie in 2001 and served that organisation as President from She has also worked as CEO of the Dutch Aphasia Association since 1996; becoming CEO of the Dutch Brain lnjury Association Hersenletsel.nl in 2014 (following the merger of the Dutch Aphasia Association with the national Stroke Association and a third organisation for people with brain injuries). In 2016, she was elected as a Board Member of the Stroke Alliance for Europe.

6 About the European Stroke Organisation The European Stroke Organisation (ESO) is a pan-european society of stroke researchers and physicians, national and regional stroke societies and lay organisations that was founded in December The ESO is an NGO comprised of individual and organisational members. The aim of the ESO is to reduce burden of stroke by changing the way that stroke is viewed and treated. This can only be achieved by professional and public education, and by making institutional changes. The ESO provides assistance in achieving this goal and in harmonising stroke management across the whole of Europe and taking action to reduce the burden of stroke regionally and globally. Europe allied against stroke. For further information, please contact: esoinfo@eso-stroke.org